Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights
The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...
Nasal Flu Vaccine Is Approved for At-Home Use
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
US FDA approves AstraZeneca's flu vaccine for self-administration
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
The Maravi Post8d
WHO grants first mpox vaccine approval to ramp up response to disease in Africa
The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, ...
Trinidad Express Newspapers9d
Take back ‘fake vaccines’ talk
Health Minister Terrence Deyalsingh has demanded that Opposition Leader Kamla Persad-Bissessar provide a “full and complete” ...
EurekAlert!9d
Vaccine adjuvants: From empirical to a more rational drug design
Vaccine adjuvants have evolved significantly since their inception, transitioning from empirical discovery to a more ...
Future Market Insights11d
Global Vaccines Market to Experience Robust Growth with a Projected CAGR of 6.6% by 2033
The global vaccines market is on the brink of remarkable expansion, with forecasts indicating a notable Compound Annual ...
The Lancet13d
Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children
hTranslational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain iGenetics, Vaccines and Infectious Diseases, Healthcare Research ...
USA Today17d
FDA approved new COVID-19 vaccines. Here's what to know and where to get them
Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...
The Washington Post18d
Coronavirus vaccines, once free, are now pricey for uninsured people
As updated coronavirus vaccines hit U.S. pharmacy shelves, adults without health insurance are discovering the shots are no longer free, instead costing up to $200. The federal Bridge Access ...